William Blair & Company
BLUE

William Blair & Company’s bluebird bio BLUE Stock Holding History

William Blair & Company’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-180
Closed -$214K – 1739
2019
Q3 		$214K Sell
180
-8
-4% -$12.2K ﹤0.01% 1243
2019
Q2 		$310K Sell
188
-9
-5% -$15.6K ﹤0.01% 1143
2019
Q1 		$402K Buy
197
+39
+25% +$68.7K ﹤0.01% 1029
2018
Q4 		$203K Buy
158
+14
+10% +$21.5K ﹤0.01% 1228
2018
Q3 		$272K Buy
+144
New +$297K ﹤0.01% 1181
2015
Q3 		– Sell
-133
Closed -$289K – 1419
2015
Q2 		$289K Sell
133
-1
-0.7% -$2.04K ﹤0.01% 1943
2015
Q1 		$210K Buy
+134
New +$177K ﹤0.01% 2004

Other funds holding BLUE

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

William Blair & Company's BLUE Position: Q4 2019 in Review

William Blair & Company sold out of bluebird bio (BLUE) in Q4 2019, closing a stake of 180 shares — an estimated $214K sold.

William Blair & Company first reported a position in BLUE in Q1 2015 and held it in 7 quarters. The position peaked at $402K in Q1 2019. 274 funds tracked by Wall St. Rank hold BLUE as of Q4 2019.

  • William Blair & Company reported no remaining bluebird bio position as of Q4 2019 after selling out during the quarter.
  • William Blair & Company sold 180 bluebird bio shares in Q4 2019, an estimated $214K.
  • William Blair & Company first reported a position in bluebird bio in Q1 2015 and held it in 7 quarters.
  • William Blair & Company's bluebird bio position peaked at $402K in Q1 2019.
  • 274 funds tracked by Wall St. Rank held bluebird bio as of Q4 2019.

Based on William Blair & Company's 13F filing for Q4 2019, filed 13 Feb 2020.